Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast Sodium immediate release tablets in the strength of 10mg and Montelukast Sodium chewable tablets in 4mg & ...

The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 ...

The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 ...

Camber Pharmaceuticals is recalling one lot of montelukast sodium tablets because the bottles are labeled "montelukast sodium tablets, 10-mg, 30-count" but actually contain 90 tablets of losartan ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Montelukast Sodium tablets 10mg (ANDA 202468) and Montelukast Sodium Chewable ...

Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on “off-odour” complaints, according to US ...

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Montelukast ...

Mylan announced the launch of the Montelukast Sodium Tablets and Chewable Tablets, the generic version of Merck‘s Singulair. Mylan has already begun shipping Montelukast Sodium Tablets 10mg and ...

Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American market. Ajanta Pharma USA Inc, a subsidiary of the company today ...

There are over 30 million people suffering from seasonal asthma of different levels worldwide, and the situation is worse in deeply contaminated countries and regions with high tobacco consumption.